Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (BEIGF) Change in Taxes (2016 - 2021)

BeOne Medicines (BEIGF) has disclosed Change in Taxes for 6 consecutive years, with $7.1 million as the latest value for Q1 2021.

  • Quarterly Change in Taxes rose 17.58% to $7.1 million in Q1 2021 from the year-ago period, while the trailing twelve-month figure was $3.4 million through Mar 2021, down 73.27% year-over-year, with the annual reading at $2.3 million for FY2020, 69.35% down from the prior year.
  • Change in Taxes for Q1 2021 was $7.1 million at BeOne Medicines, down from $14.6 million in the prior quarter.
  • The five-year high for Change in Taxes was $14.6 million in Q4 2020, with the low at -$9.3 million in Q3 2020.
  • Average Change in Taxes over 5 years is $1.2 million, with a median of $969000.0 recorded in 2019.
  • The sharpest move saw Change in Taxes skyrocketed 5251.52% in 2017, then crashed 1730.22% in 2018.
  • Over 5 years, Change in Taxes stood at $6.3 million in 2017, then tumbled by 32.55% to $4.3 million in 2018, then increased by 3.32% to $4.4 million in 2019, then soared by 232.14% to $14.6 million in 2020, then crashed by 51.0% to $7.1 million in 2021.
  • According to Business Quant data, Change in Taxes over the past three periods came in at $7.1 million, $14.6 million, and -$9.3 million for Q1 2021, Q4 2020, and Q3 2020 respectively.